Detalus Advisors’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,666
Closed -$185K 165
2024
Q3
$185K Buy
20,666
+10
+0% +$103 0.06% 149
2024
Q2
$250K Sell
20,656
-3
-0% -$51 0.09% 121
2024
Q1
$448K Buy
20,659
+24
+0.1% +$533 0.16% 84
2023
Q4
$539K Sell
20,635
-493
-2% -$11K 0.22% 73
2023
Q3
$470K Sell
21,128
-824
-4% -$21.9K 0.22% 77
2023
Q2
$625K Buy
21,952
+7,105
+48% +$231K 0.28% 61
2023
Q1
$513K Buy
14,847
+1,004
+7% +$35.6K 0.25% 75
2022
Q4
$517K Buy
13,843
+4,004
+41% +$151K 0.25% 77
2022
Q3
$309K Buy
9,839
+154
+2% +$5.71K 0.19% 93
2022
Q2
$367K Buy
+9,685
New +$416K 0.22% 77

Other funds holding WBA

Detalus Advisors's WBA Position: Q4 2024 in Review

Detalus Advisors sold out of Walgreens Boots Alliance (WBA) in Q4 2024, closing a stake of 20,666 shares — an estimated $185K sold.

Detalus Advisors first reported a position in WBA in Q2 2022 and held it in 10 quarters. The position peaked at $625K in Q2 2023. 881 funds tracked by Wall St. Rank hold WBA as of Q4 2024.

  • Detalus Advisors reported no remaining Walgreens Boots Alliance position as of Q4 2024 after selling out during the quarter.
  • Detalus Advisors sold 20,666 Walgreens Boots Alliance shares in Q4 2024, an estimated $185K.
  • Detalus Advisors first reported a position in Walgreens Boots Alliance in Q2 2022 and held it in 10 quarters.
  • Detalus Advisors's Walgreens Boots Alliance position peaked at $625K in Q2 2023.
  • 881 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q4 2024.

Based on Detalus Advisors's 13F filing for Q4 2024, filed 6 Feb 2025.